BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 158 filers reported holding BLUEBIRD BIO INC in Q1 2024. The put-call ratio across all filers is 1.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $128,442 | -89.5% | 93,074 | -75.1% | 0.00% | -87.5% |
| Q2 2023 | $1,228,776 | +145.1% | 373,488 | +415.5% | 0.01% | +166.7% |
| Q4 2022 | $501,396 | -82.5% | 72,456 | -84.0% | 0.00% | -81.2% |
| Q3 2022 | $2,872,000 | +625.3% | 453,763 | +374.8% | 0.02% | +700.0% |
| Q2 2022 | $396,000 | -32.3% | 95,567 | -20.8% | 0.00% | -60.0% |
| Q1 2022 | $585,000 | -64.4% | 120,592 | +40.2% | 0.01% | -76.2% |
| Q3 2021 | $1,643,000 | -66.4% | 85,986 | -43.7% | 0.02% | -61.8% |
| Q2 2021 | $4,886,000 | +2.1% | 152,774 | -3.7% | 0.06% | -9.8% |
| Q1 2021 | $4,786,000 | -4.5% | 158,725 | +37.1% | 0.06% | -11.6% |
| Q4 2020 | $5,010,000 | +236.0% | 115,789 | +319.0% | 0.07% | +213.6% |
| Q3 2020 | $1,491,000 | +51.2% | 27,636 | +71.1% | 0.02% | +29.4% |
| Q2 2020 | $986,000 | -74.2% | 16,149 | -80.6% | 0.02% | -83.7% |
| Q1 2020 | $3,829,000 | +55.5% | 83,314 | +196.9% | 0.10% | +131.1% |
| Q4 2019 | $2,463,000 | +41.6% | 28,066 | +48.2% | 0.04% | +28.6% |
| Q3 2019 | $1,739,000 | -68.8% | 18,936 | -56.8% | 0.04% | -65.7% |
| Q2 2019 | $5,576,000 | +723.6% | 43,835 | +918.7% | 0.10% | +363.6% |
| Q1 2019 | $677,000 | -17.9% | 4,303 | -48.3% | 0.02% | -43.6% |
| Q4 2018 | $825,000 | +9066.7% | 8,318 | +13536.1% | 0.04% | – |
| Q3 2018 | $9,000 | -99.8% | 61 | -99.7% | 0.00% | -100.0% |
| Q2 2018 | $3,767,000 | +78.3% | 24,000 | +94.0% | 0.19% | +52.4% |
| Q1 2018 | $2,113,000 | +510.7% | 12,372 | +536.4% | 0.12% | +588.9% |
| Q4 2017 | $346,000 | +34.6% | 1,944 | -20.4% | 0.02% | +12.5% |
| Q2 2017 | $257,000 | +497.7% | 2,443 | +249.0% | 0.02% | +433.3% |
| Q4 2016 | $43,000 | +115.0% | 700 | +133.3% | 0.00% | +200.0% |
| Q3 2016 | $20,000 | +53.8% | 300 | +3.4% | 0.00% | 0.0% |
| Q2 2016 | $13,000 | -99.2% | 290 | -99.2% | 0.00% | -98.9% |
| Q1 2016 | $1,634,000 | -0.2% | 38,443 | +50.8% | 0.09% | -3.1% |
| Q4 2015 | $1,637,000 | -51.9% | 25,490 | -36.0% | 0.10% | -44.2% |
| Q3 2015 | $3,406,000 | +62.4% | 39,812 | +219.6% | 0.17% | +68.6% |
| Q2 2015 | $2,097,000 | +38.4% | 12,456 | -0.7% | 0.10% | +37.8% |
| Q1 2015 | $1,515,000 | +6487.0% | 12,543 | +4838.2% | 0.07% | +7300.0% |
| Q4 2014 | $23,000 | – | 254 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,964,000 | $59,215,000 | 1.36% |
| Birchview Capital, LP | 75,500 | $2,276,000 | 1.35% |
| Camber Capital Management LP | 1,000,000 | $30,150,000 | 1.04% |
| Sessa Capital IM, L.P. | 875,000 | $26,381,000 | 1.02% |
| Bain Capital Life Sciences Investors, LLC | 538,179 | $16,226,000 | 0.92% |
| Tarsadia Capital, LLC | 100,000 | $3,015,000 | 0.81% |
| Bullseye Asset Management LLC | 67,872 | $2,046,000 | 0.76% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,304,246 | $39,323,000 | 0.58% |
| MANGROVE PARTNERS IM, LLC | 175,178 | $5,282,000 | 0.53% |
| Parametrica Management Ltd | 37,712 | $1,080,000 | 0.52% |